| |
|
|
|
Xtalks, Online
2024-05-08
Cell therapy represents a groundbreaking frontier in medical treatment, presenting unprecedented potential for addressing a diverse array of medical conditions where traditional therapies have fallen short. However, the successful execution of cell therapy clinical trials demands meticulous attention to detail from clinical sites to safeguard patient welfare, uphold regulatory standards and achieve trial objectives.
In this webinar, the expert speakers will delve into the critical components of site readiness, encompassing specialized infrastructure and training essential for the proper management of cell therapy products. Additionally, they will explore pivotal aspects of patient selection criteria, safety protocols and emerging trends in non-oncology clinical trial research, illuminating key considerations for navigating this dynamic landscape.
Register for this webinar today to learn key considerations of cell therapy trials, from clinical site readiness to ensuring patient safety, all while meeting trial goals.
Keywords: Clinical Trials, Drug Development, Clinical Research, CRO, Patient Recruitment, Cell Therapy, Clinical Sites, Cell Therapy Trials, Cell & Gene Therapies, Sites
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
John Hamlet, Executive Director, Neuroscience, PPD clinical research business of Thermo Fisher Scientific
Nora Carroll, PhD, MPH, Senior Director, Project Delivery, PPD clinical research business of Thermo Fisher Scientific
Marcie Weil, MD, Medical Director, PPD clinical research business of Thermo Fisher Scientific
Jennifer Pietrowski, Senior Director, Project Management, PPD clinical research business of Thermo Fisher Scientific
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-05-08
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|